SUBSCRIBE Subscribe to our RSS Feed

CMLHope.Com

A Worldwide Support Network For Chronic Myelogenous Leukemia

  • home
  • About
  • Contact
  • Sponsored By RealEstateZoo.Com

Archives

  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
  • February 2006
  • January 2006
  • December 2005
  • November 2005
  • October 2005
  • September 2005
  • August 2005
  • July 2005
  • June 2005
  • May 2005
  • April 2005
  • March 2005
  • February 2005
  • January 2005
  • December 2004
  • November 2004
  • October 2004
  • September 2004
  • August 2004
  • July 2004
  • June 2004

Recent Posts

  • Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome.
  • Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus.
  • miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts.
  • Granulocytic sarcoma of the small intestine: an unusual presentation of acute myelogenous leukaemia.
  • A fertile XY/XX chimeric male with chronic myeloid leukemia in a minor 46,XX cell line and a history of polycythemia vera and trisomy 9 in the major 46,XY cell line.
  • [Analysis of long-term treatment outcome and related factors in 95 chronic myeloid leukemia patients treated with imatinib]
  • [Efficacy and safety of imatinib in treatment of 151 chronic myeloid leukemia patients]
  • Overexpression of Apg-2 increases cell proliferation and protects from oxidative damage in BaF3-BCR/ABL cells.
  • Molecular Monitoring of BCR-ABL Transcripts in Patients With Chronic Myelogenous Leukemia: Is High Sensitivity of Clinical Value?
  • Reduced proliferation of non-megakaryocytic acute myelogenous leukemia and other leukemia and lymphoma cell lines in response to eltrombopag.
  • Blockade of the ERK or PI3K-Akt signaling pathway enhances the cytotoxicity of histone deacetylase inhibitors in tumor cells resistant to gefitinib or imatinib.
  • SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations.
  • Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients.
  • Cytotoxic effect of flavonoids on leukemia cells and normal cells of human blood.
  • Summary of 615 patients of chronic myeloid leukemia in Shanghai from 2001 to 2006

 

December 2006
M T W T F S S
« Nov   Jan »
 123
45678910
11121314151617
18192021222324
25262728293031

Meta

  • Log in
  • Entries RSS
  • Comments RSS
  • WordPress.org

CML Articles 12/11/2006

Posted by rob on December 11, 2006 under Uncategorized | Be the First to Comment

Recurrent disseminated skin lesions due to Metarrhizium anisopliae in an adult patient with acute myelogenous leukaemia.
Maculopapular skin rashes associated with high-dose chemotherapy: prevalence and risk factors.
[Attentive questions about treatment of chronic myelogenous leukemia with imatinib mesylate]
[Effects
and prognostic factors of HLA-matched sibling donor allogeneic
hematopoietic stem cell transplantation for chronic myelogenous
leukemia]
Dose Modification of Imatinib by Monitoring the Level of BCR-ABL Transcript in Chronic Myelogenous Leukemia.
Targeted Degradation of the AML1/MDS1/EVI1 Oncoprotein by Arsenic Trioxide.
RALBP1/RLIP76 mediates multidrug resistance.
A Primitive Cell Origin for B-Cell Precursor ALL?
A new biodegradable and biocompatible hydrogel with polyaminoacid structure.

Lights

Posted by rob on December 9, 2006 under Uncategorized | Be the First to Comment

From chutney bannister

home top

Site Information

© 2010 CMLHope.Com
Ministry Free Theme
by eGrace Creative.

Pages

  • Home
  • About
  • Contact
  • Sponsored By RealEstateZoo.Com

Blogroll

    Contributors

    • MedWorm Query: +chronic +myelogenous +leukemia
    • pubmed: myelogenous